This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Rhabdomyolysis and fluvoxamine

Authoring team

Rhabdomyolysis and fluvoxamine

Myalgia is a rare side effect of fluvoxamine (1).

A case report (1) describes rhabdomyolysis due to fluvoxamine monotherapy for obsessive-compulsive disorder

  • a young adolescent developed pain in the extremities, and an increase in serum creatine kinase (CK) and myoglobin during fluvoxamine treatment
  • adverse reactions were reversed immediately after the medicine was changed to another SSRI - sertraline

Reference:

  • Zhang F, Gong W, Cui Z, et al. Rhabdomyolysis in a male adolescent associated with monotherapy of fluvoxamine. European Journal of Hospital Pharmacy Published Online First: 02 December 2022. doi: 10.1136/ejhpharm-2022-00353

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.